GUARDI.HEALTH NEW DL-,001
GUARDI.HEALTH NEW DL-,001
Aktie · US40145Q5009 · GHSI · A3D4VB (XNCM)
Übersicht
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
1
1
0
0
Kein Kurs
10.02.2026 21:00
Aktuelle Kurse von GUARDI.HEALTH NEW DL-,001
BörseTickerWährungLetzter UmsatzKursTagesveränderung
OTC: UTC
UTC
GHSI
USD
10.02.2026 21:00
3,25 USD
-
Free Float & Liquidität
Free Float 90,38 %
Shares Float 1,16 M
Ausstehende Aktien 1,28 M
Firmenprofil zu GUARDI.HEALTH NEW DL-,001 Aktie
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
KI-Analyse von GUARDI.HEALTH NEW DL-,001
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu GUARDI.HEALTH NEW DL-,001
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name GUARDI.HEALTH NEW DL-,001
Firma Guardion Health Sciences, Inc.
Symbol GHSI
Website https://www.guardionhealth.com
Heimatbörse XNCM Frankfurt
WKN A3D4VB
ISIN US40145Q5009
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Mark Goldstone
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 15150 Avenue of Science, 92128 San Diego
IPO Datum 2019-04-05
Dividenden von 'GUARDI.HEALTH NEW DL-,001'
Ex-Datum Dividende pro Aktie
09.09.2024 5,00 USD

Aktien-Splits

Datum Split
09.01.2023 1:50
01.03.2021 1:6

Ticker Symbole

Name Symbol
NASDAQ GHSI
Weitere Aktien
Investoren, die GUARDI.HEALTH NEW DL-,001 halten, haben auch folgende Aktien im Depot:
BSK 1818     PF.S.563
BSK 1818 PF.S.563 Anleihe
Sundrug Co.,Ltd.
Sundrug Co.,Ltd. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026